Home Cart Sign in  
Chemical Structure| 66575-29-9 Chemical Structure| 66575-29-9

Structure of Forskolin
CAS No.: 66575-29-9

Chemical Structure| 66575-29-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Forskolin is a ubiquitous activator of eukaryotic adenylyl cyclase (AC) in a wide variety of cell types with binding (IC50=41 nM) to and activation (EC50=0.5 μM) of type I adenylyl cyclase. It is commonly used to raise levels of cAMP in the research of cell physiology.

Synonyms: Coleonol; Colforsin; NSC 375489

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Forskolin

CAS No. :66575-29-9
Formula : C22H34O7
M.W : 410.50
SMILES Code : CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O
Synonyms :
Coleonol; Colforsin; NSC 375489
MDL No. :MFCD00082317
InChI Key :OHCQJHSOBUTRHG-KGGHGJDLSA-N
Pubchem ID :47936

Safety of Forskolin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H312
Precautionary Statements:P280

Related Pathways of Forskolin

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293A cells 1–10 μM 1 h To assess the inhibitory effect of Forskolin on mTORC1 activity Elife. 2019 May 21;8:e43038.
MEF cells 10 μM 1 h To assess the inhibitory effect of Forskolin on mTORC1 activity Elife. 2019 May 21;8:e43038.
HEK293T cells 30 μM 30 min Enhanced the interaction between DAGLα and ankyrin-G Biol Psychiatry. 2021 Aug 15;90(4):263-274.
GLUTag cells 10 μM 15 min and 30 min Measure cAMP concentration and PKA activity Gut Microbes. 2021 Jan-Dec;13(1):1987782.
WT cells 10 µM 48 h To investigate the effect of Forskolin on cell respiration and ATP synthesis, results showed that Forskolin increased cell respiration and ATP synthesis. EMBO Mol Med. 2009 Nov;1(8-9):392-406.
CHO-K1 cells 20 µM 30 min Activate PKA to study its effect on KCTD12-induced K+ current desensitization. Results showed that PKA activation significantly slowed KCTD12-induced fast desensitization. Biochem Pharmacol. 2014 Oct 1;91(3):369-79.
Hippocampal neurons 20 µM 30 min Activate PKA to study its effect on KCTD12-induced K+ current desensitization. Results showed that PKA activation significantly slowed KCTD12-induced fast desensitization. Biochem Pharmacol. 2014 Oct 1;91(3):369-79.
MIN6 cells 10 μM 30 min To assess cAMP production, results showed that forskolin-stimulated cAMP production was significantly reduced in Npas4-overexpressing MIN6 cells Diabetes. 2013 Aug;62(8):2808-20.
ScN2a-cl3 cells 1 μM 7 days To evaluate the effect of Forskolin on PrPSc levels in differentiated cells. Results showed that Forskolin did not lead to a rebound in PrPSc levels. PLoS Pathog. 2009 Nov;5(11):e1000673.
Primary cortical neurons 30 μM 30 min Increased the interaction between DAGLα and ankyrin-G and regulated dendritic spine morphology Biol Psychiatry. 2021 Aug 15;90(4):263-274.
SKOV3 cells 20 μM 30 to 40 min Induced endogenous EPAC1 nuclear oligomer formation Nat Commun. 2023 Sep 8;14(1):5521
HUVEC cells 20 μM 30 to 40 min Induced endogenous EPAC1 nuclear oligomer formation Nat Commun. 2023 Sep 8;14(1):5521
HEK cells 20 μM 30 to 40 min Induced EPAC1-YFP nuclear oligomer formation Nat Commun. 2023 Sep 8;14(1):5521

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice PSNL and CFA models Oral 2 mg/kg Once daily for 14–33 days Forskolin reversed the PSNL- or CFA-induced decrease in PKA and CREB phosphorylation and BDNF expression, and partially reversed mechanical hypersensitivity and depression-like behaviors Int J Neuropsychopharmacol. 2024 Oct 1;27(10):pyae040
Mice Not specified Intraperitoneal injection 1 mg/kg Single dose, lasting 30 minutes Enhance endothelial cell barrier function, reduce permeability and immune complex deposition J Exp Med. 2004 Oct 4;200(7):835-46
Mice WT and AnkG cKO mice Intraperitoneal injection 0.2 mg/kg Single injection, behavioral tests conducted 30 minutes after injection Evaluated the effect of forskolin on depression- and anxiety-related behaviors, finding that forskolin could not reverse depression-related behavior in AnkG cKO mice but could reverse anxiety-related behavior Biol Psychiatry. 2021 Aug 15;90(4):263-274.

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03390985 - Completed - -
NCT02586883 Idiopathic Dilation of the Bro... More >>nchi Less << Not Applicable Recruiting April 2020 France ... More >> Necker-Enfants Malades Hospital Recruiting Paris, France, 75015 Contact: Isabelle SERMET-GAUDELUS, MD, PhD    +33144494887    isabelle.sermet@nck.aphp.fr Less <<
NCT03455153 - Completed - United Kingdom ... More >> Lindum Medical Practice Lincoln, Lincolnshire, United Kingdom, LN2 2JP Nettleham Medical Practice Lincoln, Lincolnshire, United Kingdom, LN2 2RS Birchwood Medical Practice Lincoln, Lincolnshire, United Kingdom, LN6 0QQ Less <<
NCT01920841 Weight Loss Not Applicable Withdrawn(Study Design changed... More >> and will be resubmitted as a new study) Less << - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT03652090 - Completed - -
NCT02143349 Metabolic Syndrome ... More >> Obesity Less << Phase 3 Unknown May 2015 Australia, Victoria ... More >> College of Health and Biomedicine Victoria University Recruiting St. Albans, Victoria, Australia, 14428 Contact: Dr. Xiao Su    +61399192318    xiao.su@vu.edu.au    Contact: A/Prof Michael Mathai    +61399192211    michael.mathai@vu.edu.au    Principal Investigator: Dr. Xiao Su          Sub-Investigator: A/Prof Michael Mathai Less <<
NCT00864578 - Withdrawn(loss of interest bef... More >>ore enrolment started) Less << June 2009 Italy ... More >> Ophthalmology Department of the University Clinic Bari, Italy, I-70124 Less <<
NCT02807415 - Recruiting June 2019 Germany ... More >> Justus-Liebig-University Recruiting Gießen, Germany, 35385 Contact: Lutz Nährlich, MD    004964198557620    lutz.naehrlich@paediat.med.uni-giessen.de    Contact: Claudia Rückes-Nilges, Dipl-Biol    004964198556945    claudia.rueckes-nilges@paediat.med.uni-giessen.de    Principal Investigator: Lutz Nährlich, MD          Sub-Investigator: Stefan Kuhnert, MD          Hannover Medical School Recruiting Hannover, Germany, 30625 Contact: Burkhard Tümmler, MD PhD    00495115322920    tuemmler.burkhard@mh-hannover.de    Contact: Christian Dopfer, MD    00495115326111    dopfer.christian@mh-hannover.de    Principal Investigator: Burkhard Tümmler, MD PhD          Sub-Investigator: Christian Dopfer, MD          University of Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Marcus Mall, MD    00496221564502    Marcus.Mall@med.uni-heidelberg.de    Contact: Simon Gräber, MD    004962215638926    Simon.Graeber@med.uni-heidelberg.de    Principal Investigator: Marcus Mall, MD          Sub-Investigator: Simon Gräber, MD          Sub-Investigator: Susanne Dittrich, MD Less <<
NCT00863811 - Withdrawn(loss of interest bef... More >>ore enrolment started) Less << July 2009 Italy ... More >> Ophthalmology Department of the University Bari, Italy, I-70124 Less <<
NCT01254006 Glaucoma Not Applicable Completed - Italy ... More >> Univerisity La Sapienza Latina, Italy Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.44mL

0.49mL

0.24mL

12.18mL

2.44mL

1.22mL

24.36mL

4.87mL

2.44mL

References

 

Historical Records

Categories